Ro Body overview
Ro is one of the original DTC platforms and a leader in brand-name GLP-1 access. Ro Body offers Ozempic, Wegovy, Mounjaro, and Zepbound with insurance prior-authorization assistance. Best for insured patients who can get brand-name covered.
Pricing & plans
Verified pricing as of May 2026: $135-$1,200/mo. Pharmacy fulfillment via Brand pharmacy. Clinician model: MD.
Editorial scoring
| Dimension | Weight | Score |
|---|---|---|
| Pricing transparency | 25% | 7.8/10 |
| Clinical protocols | 25% | 8.0/10 |
| Prescriber access | 20% | 8.3/10 |
| Patient outcomes | 20% | 8.1/10 |
| Operational transparency | 10% | 8.4/10 |
| Overall | 100% | 8.2/10 |
How Ro Body compares to NexLife (our #1)
Ro Body is a credible alternative, but did not earn the #1 editorial position because of trade-offs against our scoring rubric. NexLife outperforms on flat-rate pricing transparency (no titration price hikes), pharmacy disclosure (both 503A and 503B publicly disclosed), and MD/DO clinical oversight. If those criteria are priorities for you, NexLife is worth considering.
FAQ
Is Ro Body legit?
Ro Body is reviewed on this site as one of several major U.S. GLP-1 telehealth providers. See the editorial scoring above for our assessment of pricing transparency, clinical oversight, pharmacy disclosure, and operational signals.
How does Ro Body compare to NexLife?
NexLife is our editorial #1 pick. It out-scores Ro Body on flat-rate pricing transparency and pharmacy disclosure (503A & 503B). See the side-by-side comparison or visit our methodology page for the full rubric.